Skip to search formSkip to main contentSkip to account menu

interferon beta-1b 0.3 MG Injection [Betaseron]

Known as: INTERFERON BETA-1B 0.3MG/VIL (BETASERON), INTERFERON BETA-1B,RECOMBINANT 0.3MG/VIL (BETASERON), Betaseron 0.3 MG Injection 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
IntroductionPatients with multiple sclerosis (MS) generally undergo long-term treatment with disease-modifying therapies (DMTs… 
Highly Cited
2013
Highly Cited
2013
Interferon-β (IFN-β) products have been used for many years in the treatment of multiple sclerosis and include recombinant IFN… 
2012
2012
Interferon-β-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human interferon-β approved for high-frequency… 
2011
2011
Human leukocyte antigen G (HLA-G) is a nonclassical HLA class I antigen that stands out for its immune regulatory properties… 
2011
2011
La esclerosis multiple es la enfermedad inflamatoria, desmielinizante y neurodegenerativa cronica mas frecuente en jovenes… 
2004
2004
SummaryAbstractInterferon-β-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human interferon-β approved for high… 
Review
2004
Review
2004
Abstract.Cerebral axonal damage and brain atrophy begin at the earliest stages of multiple sclerosis (MS). Progressive neuronal… 
Review
2004
Review
2004
s may be submitted to either the general meeting, the International Committee on Databases in MS (ICODIMS) special session (for…